Citations

Citations to this article as recorded by  

• Fecal calprotectin as a factor that supports the pathogenicity of Dientamoeba fragilis
  Mehmet Aykur, Guliz Armagan, Rukiye Vardar, Hande Dagci
  Microbial Pathogenesis.2020; 139: 103868.     CrossRef
• Predictive values of stool-based tests for mucosal healing among Taiwanese patients with ulcerative colitis: a retrospective cohort analysis
  Hsu-Heng Yen, Mei-Wen Chen, Yu-Yao Chang, Hsuan-Yuan Huang, Tsui-Chun Hsu, Yang-Yuan Chen
  PeerJ.2020; 8: e9537.     CrossRef
• What is the appropriate cut-off value of CRP to predict endoscopic remission in patients with ulcerative colitis in clinical remission?
  Jongbeom Shin, Sung Min Kong, Gyeol Seong, Young-Ho Kim
  International Journal of Colorectal Disease.2020; 35(12): 2249.     CrossRef
• Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates
  Hau-Jyun Su, Yu-Tse Chiu, Chuan-Tai Chiu, Yen-Chun Lin, Chen-Yu Wang, Jui-Ying Hsieh, Shu-Chen Wei
  Journal of the Formosan Medical Association.2019; 118(7): 1083.     CrossRef
• Monitoring Disease Activity: How and When?
  Kang-Moon Lee
  The Korean Journal of Gastroenterology.2018; 71(2): 69.     CrossRef
• Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring
  Shu-Chen Wei, Chien-Chih Tung, Meng-Tzu Weng, Jau-Min Wong
  Intestinal Research.2018; 16(4): 546.     CrossRef
• Home-based fecal calprotectin test is expected to play an important role in patients with inflammatory bowel diseases
  Young-Ho Kim
  Intestinal Research.2018; 16(4): 507.     CrossRef
• Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis
  Sun-Ho Lee, Min-Ju Kim, Kiju Chang, Eun Mi Song, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
  BMC Gastroenterology.2017;[Epub]     CrossRef
• Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease
  Hyun Jung Lee, Jae Hee Cheon
  Intestinal Research.2017; 15(3): 311.     CrossRef

Irritable bowel syndrome (IBS), a common gastrointestinal disorder involving the gut-brain axis, and inflammatory bowel disease (IBD), a chronic relapsing inflammatory disorder, are both increasing in incidence and prevalence in Asia. Both have significant overlap in terms of symptoms, pathophysiology, and treatment, suggesting the possibility of IBS and IBD being a single disease entity albeit at opposite ends of the spectrum. We examined the similarities and differences in IBS and IBD, and offer new thoughts and approaches to the disease paradigm.

Citations

Citations to this article as recorded by  

• Comparative characteristics of fatigue in irritable bowel syndrome and inflammatory bowel disease: A systematic review and meta-analysis
  Yeon-Jae Kim, Seul-Gi Lee, Jin-Seok Lee, Yu-Jin Choi, Chang-Gue Son
  Journal of Psychosomatic Research.2024; 177: 111589.     CrossRef
• Recent Trends in Non-Invasive Methods of Diagnosis and Evaluation of Inflammatory Bowel Disease: A Short Review
  Dan Vălean, Roxana Zaharie, Roman Țaulean, Lia Usatiuc, Florin Zaharie
  International Journal of Molecular Sciences.2024; 25(4): 2077.     CrossRef
• Sources of diagnostic delay for people with Crohn’s disease and ulcerative colitis: Qualitative research study
  Valérie Pittet
  PLOS ONE.2024; 19(6): e0301672.     CrossRef
• Early life adverse exposures in irritable bowel syndrome: new insights and opportunities
  Guo Qiong Zhou, Meng Jie Huang, Xin Yu, Na Na Zhang, Shan Tao, Ming Zhang
  Frontiers in Pediatrics.2023;[Epub]     CrossRef
• Evaluation of the Cost-Utility of the York Faecal Calprotectin Care Pathway
  Hayden Holmes, Jessica McMaster, Heather Davies, Victoria Vaines, James Turvill
  Expert Review of Pharmacoeconomics & Outcomes Research.2022; 22(3): 521.     CrossRef
• Clinical Efficacy of Probiotic Therapy on Bowel-Related Symptoms in Patients with Ulcerative Colitis during Endoscopic Remission: An Observational Study
  Jin Lee, Su Bum Park, Hyung Wook Kim, Hong Sub Lee, Sam Ryong Jee, Jong Hun Lee, Tae Oh Kim, Chiara Ricci
  Gastroenterology Research and Practice.2022; 2022: 1.     CrossRef
• The Prevalence and Incidence of Irritable Bowel Syndrome and Inflammatory Bowel Disease in Depression and Bipolar Disorder: A Systematic Review and Meta-Analysis
  Viktoriya L. Nikolova, Lucy Pelton, Calum D. Moulton, Daniele Zorzato, Anthony J. Cleare, Allan H. Young, James M. Stone
  Psychosomatic Medicine.2022; 84(3): 313.     CrossRef
• Exploring the Gut Microbiome in Myasthenia Gravis
  Angel Yun-Kuan Thye, Jodi Woan-Fei Law, Loh Teng-Hern Tan, Sivakumar Thurairajasingam, Kok-Gan Chan, Vengadesh Letchumanan, Learn-Han Lee
  Nutrients.2022; 14(8): 1647.     CrossRef
• Association between body mass index and fecal calprotectin levels in children and adolescents with irritable bowel syndrome
  Jun Hwan Kim, Dae Yong Yi, Yoo Min Lee, You Jin Choi, Ju Young Kim, Yong Hee Hong, Ji Young Park, Su Yeong Kim, Na Mi Lee, Sin Weon Yun, Soo Ahn Chae, In Seok Lim, Eung Sang Choi, In Sook Jeong
  Medicine.2022; 101(32): e29968.     CrossRef
• Prevalence and risk factors of bowel symptoms in Korean patients with ulcerative colitis in endoscopic remission: a retrospective study
  Kwangwoo Nam, Sang Hyoung Park, Jun Ho Oh, Ho-Su Lee, Soomin Noh, Jae Cheol Park, Jin Yong Kim, Eun Hye Oh, Jeongseok Kim, Nam Seok Ham, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang
  BMC Gastroenterology.2021;[Epub]     CrossRef
• Episodic, severe abdominal pain due to isolated jejunal Crohn’s disease
  Trilokesh D. Kidambi, Yu Liang, Pejman Motarjem, Rizvan Mirza, Alice Han, Marjorie Hein, Dupinder Singh, James L. Lin, Cornelia Banciu-Odell, Robert Toroussian, Michael W. Lew, Saro Manoukian
  Clinical Journal of Gastroenterology.2021; 14(4): 1084.     CrossRef
• Double-Barrel Shotgun: Probiotic Lactic Acid Bacteria with Antiviral Properties Modified to Serve as Vaccines
  Leon M. T. Dicks, Matthew J. Grobbelaar
  Microorganisms.2021; 9(8): 1565.     CrossRef
• Altered Intestinal Permeability and Drug Repositioning in a Post-operative Ileus Guinea Pig Model
  Young Min Kim, Zahid Hussain, Young Ju Lee, Hyojin Park
  Journal of Neurogastroenterology and Motility.2021; 27(4): 639.     CrossRef
• STW 5 Herbal Preparation Modulates Wnt3a and Claudin 1 Gene Expression in Zebrafish IBS-like Model
  Monica Piccione, Nicola Facchinello, Sandra Schrenk, Marco Gasparella, Surajit Pathak, Ramy M. Ammar, Sabine Rabini, Luisa Dalla Valle, Rosa Di Liddo
  Pharmaceuticals.2021; 14(12): 1234.     CrossRef
• Endocannabinoid system in irritable bowel syndrome and cannabis as a therapy
  Samiksha Pandey, Saima Kashif, Mina Youssef, Somia Sarwal, Hala Zraik, Ripudaman Singh, Ian H. Rutkofsky
  Complementary Therapies in Medicine.2020; 48: 102242.     CrossRef
• Epithelial–Neuronal Communication in the Colon: Implications for Visceral Pain
  Sarah A. Najjar, Brian M. Davis, Kathryn M. Albers
  Trends in Neurosciences.2020; 43(3): 170.     CrossRef
• Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome
  Alicia Fournier, Laurie Mondillon, Olivier Luminet, Fréderic Canini, Nicolas Mathieu, Anne Sophie Gauchez, Cécile Dantzer, Bruno Bonaz, Sonia Pellissier
  Frontiers in Psychiatry.2020;[Epub]     CrossRef
• Potent In Vitro Activity of Citrus aurantium Essential Oil and Vitis vinifera Hydrolate Against Gut Yeast Isolates from Irritable Bowel Syndrome Patients—The Right Mix for Potential Therapeutic Use
  Maura Di Vito, Maria Grazia Bellardi, Maurizio Sanguinetti, Francesca Mondello, Antonietta Girolamo, Lorenzo Barbanti, Stefania Garzoli, Manuela Sabatino, Rino Ragno, Alberto Vitali, Ivana Palucci, Brunella Posteraro, Antonio Gasbarrini, Gian Maria Prati,
  Nutrients.2020; 12(5): 1329.     CrossRef
• The effects of gastrointestinal symptoms on structural grey matter volume in youth
  Atiqa F. Pirwani, Zhuo Fang, Bo Li, Andra Smith, Georg Northoff, Nafissa Ismail
  International Journal of Developmental Neuroscience.2020; 80(6): 477.     CrossRef
• High-Fat Diet and Antibiotics Cooperatively Impair Mitochondrial Bioenergetics to Trigger Dysbiosis that Exacerbates Pre-inflammatory Bowel Disease
  Jee-Yon Lee, Stephanie A. Cevallos, Mariana X. Byndloss, Connor R. Tiffany, Erin E. Olsan, Brian P. Butler, Briana M. Young, Andrew W.L. Rogers, Henry Nguyen, Kyongchol Kim, Sang-Woon Choi, Eunsoo Bae, Je Hee Lee, Ui-Gi Min, Duk-Chul Lee, Andreas J. Bäuml
  Cell Host & Microbe.2020; 28(2): 273.     CrossRef
• Tylophora indica (Burm. f.) merr: An insight into phytochemistry and pharmacology
  Ritika Gururani, Saraswati Patel, Neetu Yaduvanshi, Jaya Dwivedi, Sarvesh Paliwal, Swapnil Sharma
  Journal of Ethnopharmacology.2020; 262: 113122.     CrossRef
• Alexithymia and Inflammatory Bowel Disease: A Systematic Review
  Gabriella Martino, Andrea Caputo, Peter Schwarz, Federica Bellone, Walter Fries, M. C. Quattropani, C. M. Vicario
  Frontiers in Psychology.2020;[Epub]     CrossRef
• Low FODMAP Diet for Functional Gastrointestinal Symptoms in Quiescent Inflammatory Bowel Disease: A Systematic Review of Randomized Controlled Trials
  Maria G. Grammatikopoulou, Dimitrios G. Goulis, Konstantinos Gkiouras, Meletios P. Nigdelis, Stefanos T. Papageorgiou, Theodora Papamitsou, Alastair Forbes, Dimitrios P. Bogdanos
  Nutrients.2020; 12(12): 3648.     CrossRef
• Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery
  Dohoon Kim, Wooseong Kim, Seongkeun Jeong, Dayoon Kim, Jin-Wook Yoo, Yunjin Jung
  Drug Delivery and Translational Research.2019; 9(1): 334.     CrossRef
• Overlapping irritable bowel syndrome and inflammatory bowel disease
  Prianka Gajula, Eamonn M. Quigley
  Minerva Gastroenterologica e Dietologica.2019;[Epub]     CrossRef
• Is fecal calprotectin always normal in children with irritable bowel syndrome?
  You Jin Choi, Su Jin Jeong
  Intestinal Research.2019; 17(4): 546.     CrossRef
• Risk of fractures at different anatomic sites in patients with irritable bowel syndrome: a nationwide population-based cohort study
  Herng-Sheng Lee, Chi-Yi Chen, Wan-Ting Huang, Li-Jen Chang, Solomon Chih-Cheng Chen, Hsin-Yi Yang
  Archives of Osteoporosis.2018;[Epub]     CrossRef
• Painful neurotrophins and their role in visceral pain
  Ana E. López-Pérez, Kulmira Nurgali, Raquel Abalo
  Behavioural Pharmacology.2018; 29(2 and 3): 120.     CrossRef
• Altered Gut Microbiota in Myasthenia Gravis
  Dongxu Qiu, Zhiwei Xia, Xiao Jiao, Jun Deng, Lei Zhang, Jing Li
  Frontiers in Microbiology.2018;[Epub]     CrossRef
• Mind–Body Interventions for Pediatric Inflammatory Bowel Disease
  Ann Ming Yeh, Anava Wren, Brenda Golianu
  Children.2017; 4(4): 22.     CrossRef
• Post-Infectious Irritable Bowel Syndrome
  Yeong Yeh Lee, Chandramouli Annamalai, Satish S. C. Rao
  Current Gastroenterology Reports.2017;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Values of serum intestinal fatty acid-binding protein, fecal calprotectin, and fecal human β-defensin 2 for predicting necrotizing enterocolitis
  Sujia Liu, Yongle Liu, Shuhua Lai, Yingling Xie, Wenlong Xiu, Changyi Yang
  BMC Pediatrics.2024;[Epub]     CrossRef
• Multimodal Ultrasound Technology Combined with Fecal Calprotectin Assessment in Clinical Studies of Inflammatory Bowel Disease
  泊辛 陈
  Advances in Clinical Medicine.2024; 14(07): 1110.     CrossRef
• The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis
  Yujin Jeong, Seong Ran Jeon, Hyun Gun Kim, Jung Rock Moon, Tae Hee Lee, Jae Young Jang, Jun-Hyung Cho, Jun Seok Park, Heesu Park, Ki-hun Lee, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Suyeon Park
  Intestinal Research.2021; 19(1): 62.     CrossRef
• The utility of faecal and urine biomarkers for small bowel diseases
  M.S. Ismail, Serhiy Semenov, Deirdre McNamara
  Current Opinion in Gastroenterology.2021; 37(3): 284.     CrossRef
• A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease
  Jong-Mi Lee, Joo Hee Jang, Ji Hyeong Ryu, Jaeeun Yoo, Bo-In Lee, Seung-Jun Kim, Eun-Jee Oh, Hsu-Heng Yen
  PLOS ONE.2021; 16(8): e0255974.     CrossRef
• Endoscopy within 7 days after detecting high calprotectin levels can be useful for therapeutic decision-making in ulcerative colitis
  Ho Min Yong, Sung-Jo Park, Seong Ran Jeon, Heesu Park, Hyun Gun Kim, Tae Hee Lee, Junseok Park, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Hyeon Jeong Goong, Suyeon Park
  Medicine.2021; 100(34): e27065.     CrossRef
• Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn’s Disease Based on Serum Levels of Proteins
  Geert D’Haens, Orlaith Kelly, Robert Battat, Mark S. Silverberg, David Laharie, Edouard Louis, Edoardo Savarino, Giorgia Bodini, Andres Yarur, Brigid S. Boland, Waqqas Afif, Xiao-jun Li, Michael Hale, Jessica Ho, Venkateswarlu Kondragunta, Benjamin Huang,
  Gastroenterology.2020; 158(3): 515.     CrossRef
• Faecal calprotectin in inflammatory bowel diseases: a review focused on meta-analyses and routine usage limitations
  Emilio J. Laserna-Mendieta, Alfredo J. Lucendo
  Clinical Chemistry and Laboratory Medicine (CCLM).2019; 57(9): 1295.     CrossRef
• Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn’s disease?
  Christopher Ma, Robert Battat, Claire E. Parker, Reena Khanna, Vipul Jairath, Brian Gordon Feagan
  Expert Review of Gastroenterology & Hepatology.2019; 13(4): 319.     CrossRef
• Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases
  Parambir S. Dulai, Laurent Peyrin-Biroulet, Silvio Danese, Bruce E. Sands, Axel Dignass, Dan Turner, Gerassimos Mantzaris, Juergen Schölmerich, Jean-Yves Mary, Walter Reinisch, William J. Sandborn
  Gastroenterology.2019; 157(4): 1032.     CrossRef
• Faecal calprotectin to detect inflammatory bowel disease: a systematic review and exploratory meta-analysis of test accuracy
  Karoline Freeman, Brian H Willis, Hannah Fraser, Sian Taylor-Phillips, Aileen Clarke
  BMJ Open.2019; 9(3): e027428.     CrossRef
• Extraction, isolation, and concentration of calprotectin antigen (S100A8/S100A9) from granulocytes
  Tom Nilsen, Siri Helen Haugen, Anders Larsson
  Health Science Reports.2018;[Epub]     CrossRef
• Fecal Immunochemical Test and Fecal Calprotectin Measurement Are Noninvasive Monitoring Tools for Predicting Endoscopic Activity in Patients with Ulcerative Colitis
  Ji Young Chang, Jae Hee Cheon
  Gut and Liver.2018; 12(2): 117.     CrossRef
• Fecal calprotectin is not superior to serum C-reactive protein or the Harvey–Bradshaw index in predicting postoperative endoscopic recurrence in Crohn’s disease
  Cristina Verdejo, Daniel Hervías, Óscar Roncero, Ángel Arias, Abdelmouneim Bouhmidi, Rufo Lorente, Irina Salueña, Alfredo J. Lucendo
  European Journal of Gastroenterology & Hepatology.2018; 30(12): 1521.     CrossRef
• Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring
  Shu-Chen Wei, Chien-Chih Tung, Meng-Tzu Weng, Jau-Min Wong
  Intestinal Research.2018; 16(4): 546.     CrossRef
• Serum Adipocytokine Levels as Surrogate Markers for Disease Activity of Crohn’s Disease
  Su Hwan Kim, Seung Hyeon Jang, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, You Sun Kim, Dong Soo Han, Joo Sung Kim
  The American Journal of the Medical Sciences.2017; 353(5): 439.     CrossRef
• Fecal biomarkers in inflammatory bowel disease: how, when and why?
  Paula Ministro, Diana Martins
  Expert Review of Gastroenterology & Hepatology.2017; 11(4): 317.     CrossRef
• Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
  Shu Chen Wei
  Intestinal Research.2016; 14(4): 293.     CrossRef

Citations

Citations to this article as recorded by  

• Possible Role of Image-Enhanced Endoscopy in the Evaluation of Mucosal Healing of Ulcerative Colitis
  Minoru Matsuura, Daisuke Saito, Jun Miyoshi, Tadakazu Hisamatsu
  Digestion.2023; 104(1): 42.     CrossRef
• Endoscopic alterations in Peyer's patches in patients with ulcerative colitis: A prospective, multicenter study
  Satoshi Hiyama, Hideki Iijima, Yuko Sakakibara, Takuya Yamada, Akira Mukai, Yuriko Otake, Toshio Yamaguchi, Manabu Araki, Shoichiro Kawai, Yoshiki Tsujii, Takahiro Inoue, Yoshito Hayashi, Shinichiro Shinzaki, Tetsuo Takehara
  Journal of Gastroenterology and Hepatology.2020; 35(7): 1143.     CrossRef
• Can narrow-band imaging of Peyer's patches predict the recurrence of ulcerative colitis?
  Yoon Jae Kim
  Intestinal Research.2016; 14(4): 295.     CrossRef

Citations

Citations to this article as recorded by  

• Epidemiological research, burden, and clinical advances of inflammatory bowel disease in China
  Hong Yang, Jiaming Qian
  Chinese Medical Journal.2024; 137(9): 1009.     CrossRef
• Laparoscopic surgery contributes to a decrease in short-term complications in surgical ulcerative colitis patients during 2008–2017: a multicenter retrospective study in China
  Zerong Cai, Xiaosheng He, Jianfeng Gong, Peng Du, Wenjian Meng, Wei Zhou, Jinbo Jiang, Bin Wu, Weitang Yuan, Qi Xue, Lianwen Yuan, Jinhai Wang, Jiandong Tai, Jie Liang, Weiming Zhu, Ping Lan, Xiaojian Wu
  Intestinal Research.2023; 21(2): 235.     CrossRef
• Differences in inflammatory bowel diseases between East and West: a Chinese perspective
  Guanglin Cui, Junling Li, Hanzhe Liu, Jann-Birger Laugsand, Zhanju Liu
  Journal of Public Health.2021; 29(1): 19.     CrossRef
• Diagnostic and Predictive Value of Immune-Related Genes in Crohn’s Disease
  Bing Yu, Yi-xin Yin, Yan-ping Tang, Kang-lai Wei, Zhi-gang Pan, Ke-Zhi Li, Xian-wen Guo, Bang-li Hu
  Frontiers in Immunology.2021;[Epub]     CrossRef
• Role of a multidisciplinary team (MDT) in the diagnosis, treatment, and outcomes of inflammatory bowel disease: a single Chinese center's experience
  Qiang Wu, Xuehong Wang, Feng Wu, Dehong Peng, Guotao Wu, Lichao Yang, Lianwen Yuan
  BioScience Trends.2021; 15(3): 171.     CrossRef
• MANAGEMENT OF ILEOCECAL CROHN’S DISEASE DURING SURGICAL TREATMENT FOR ACUTE APPENDICITIS: A SYSTEMATIC REVIEW
  Abel Botelho QUARESMA, Eron Fabio MIRANDA, Paulo Gustavo KOTZE
  Arquivos de Gastroenterologia.2021; 58(4): 560.     CrossRef
• Risk factors and long-term outcome of disease extent progression in Asian patients with ulcerative colitis: a retrospective cohort study
  Yun Qiu, Baili Chen, Yufei Li, Shanshan Xiong, Shenghong Zhang, Yao He, Zhirong Zeng, Shomron Ben-Horin, Minhu Chen, Ren Mao
  BMC Gastroenterology.2019;[Epub]     CrossRef
• Initial medical and surgical management of inflammatory bowel disease in the biologic era: A comparison between the United States and China
  Sanskriti Varma, Jun Hu, Ambar Mehta, Yiran Song, Angela Park, Min Zhi, Susan Hutfless
  JGH Open.2019; 3(3): 234.     CrossRef
• Can molecular stratification improve the treatment of inflammatory bowel disease?
  Claire Wang, Hannah M. Baer, Daniel R. Gaya, Robert J.B. Nibbs, Simon Milling
  Pharmacological Research.2019; 148: 104442.     CrossRef
• Intrarectally administered polaprezinc attenuates the development of dextran sodium sulfate‑induced ulcerative colitis in mice
  Zhaoyang Liu, Wenbo Xie, Mingru Li, Jing Liu, Xiao Liang, Tao Li
  Experimental and Therapeutic Medicine.2019;[Epub]     CrossRef
• Changing treatment paradigms for the management of inflammatory bowel disease
  Jong Pil Im, Byong Duk Ye, You Sun Kim, Joo Sung Kim
  The Korean Journal of Internal Medicine.2018; 33(1): 28.     CrossRef
• Is Adsorptive Granulocyte and Monocyte Apheresis Effective as an Alternative Treatment Option in Patients with Ulcerative Colitis?
  Seong Ran Jeon
  Gut and Liver.2017; 11(2): 171.     CrossRef

Citations

Citations to this article as recorded by  

• S3-Leitlinie Heimenterale und heimparenterale Ernährung der Deutschen Gesellschaft für Ernährungsmedizin (DGEM)
  Stephan C. Bischoff, Jann Arends, Christiane Decker-Baumann, Elisabeth Hütterer, Sebastian Koch, Stefan Mühlebach, Ingeborg Roetzer, Andrea Schneider, Claudia Seipt, Ralph Simanek, Zeno Stanga
  Aktuelle Ernährungsmedizin.2024; 49(02): 73.     CrossRef
• Percutaneous radiologic gastrostomy versus percutaneous endoscopic gastrostomy for enteral feeding: A systematic review and meta‐analysis
  Matheus Coelho Meine, Isabela Ho Tusato, Nathalia Hoffmeister, Gilmara Coelho Meine
  Journal of Parenteral and Enteral Nutrition.2024; 48(6): 667.     CrossRef
• Direct Percutaneous Endoscopic Gastrostomy Versus Radiological Gastrostomy in Patients Unable to Undergo Transoral Endoscopic Pull Gastrostomy
  Divyanshoo R. Kohli, Craig Smith, Omer Chaudhry, Madhav Desai, Dion DePaolis, Prateek Sharma
  Digestive Diseases and Sciences.2023; 68(3): 852.     CrossRef
• Complications of Percutaneous Radiologic Gastrostomy Among Patients in a Tertiary Care Hospital in Riyadh, Saudi Arabia
  Najla Alrasheed, Haneen S Khair, Renad M Aljohani, Noof M Alharbi, Nahlah N Alotaibi, Shahad F AlEdrees, Aamir Omair
  Cureus.2023;[Epub]     CrossRef
• A retrospective study of outcomes and the validation of the Sheffield Gastrostomy Score in PEGs, RIGs and PIGs
  Heather Parr, Lloyd Thomas, Prabhsimran Singh, Salma Mohammed, Khin Nu, John S. Kane, Fred Lee, Thomas Welbank, Andrew D. Hopper, Mark E. McAlindon, Elizabeth A. Williams, David S. Sanders
  Scandinavian Journal of Gastroenterology.2023; 58(12): 1542.     CrossRef
• Endoscopic vs radiologic gastrostomy for enteral feeding: A systematic review and meta-analysis
  Evellin Souza Valentim dos Santos, Guilherme Henrique Peixoto de Oliveira, Diogo Turiani Hourneaux de Moura, Bruno Salomão Hirsch, Roberto Paolo Trasolini, Wanderley Marques Bernardo, Eduardo Guimarães Hourneaux de Moura
  World Journal of Meta-Analysis.2023; 11(6): 277.     CrossRef
• Outcomes of push and pull percutaneous endoscopic gastrostomy placements in 854 patients: A single‐center study
  Hicham Bouchiba, Maarten A J M Jacobs, Gerd Bouma, Dewkoemar Ramsoekh
  JGH Open.2022; 6(1): 57.     CrossRef
• Factors affecting late complications of percutaneous endoscopic gastrostomy tube replacement
  Kasenee Tiankanon, Satimai Aniwan, Julalak Karuehardsuwan, Sumitra Wiangngoen, Rungsun Rerknimitr
  Clinical Nutrition ESPEN.2022; 49: 378.     CrossRef
• The Outcomes of Nutritional Support Techniques in Patients with Gastrointestinal Cancers
  Vlad-Alexandru Ionescu, Gina Gheorghe, Ruxandra Oprita, Madalina Stan-Ilie, Raluca-Ioana Dascalu, Ondin Zaharia, Viorel Jinga, Camelia Cristina Diaconu, Gabriel Constantinescu
  Gastroenterology Insights.2022; 13(3): 245.     CrossRef
• Improving 30-day mortality after PEG tube placement in England from 2007 to 2019: a retrospective national cohort analysis of 87,862 patients
  Umair Kamran, Pui Chi Lee, Ben Coupland, Abdullah Abbasi, Helen Steed, Sissi Ispoglou, Fumi Varyani, Nigel Trudgill
  Gastrointestinal Endoscopy.2022; 96(6): 943.     CrossRef
• Outcomes following percutaneous endoscopic gastrostomy versus fluoroscopic procedures in the Medicare population
  Samantha Maasarani, Syed I. Khalid, Chantal Creighton, Athena J. Manatis-Lornell, Aaron L. Wiegmann, Samantha L. Terranella, Nicholas J. Skertich, Laura DeCesare, Edie Y. Chan
  Surgery Open Science.2021; 3: 2.     CrossRef
• Safety of endoscopic gastrostomy tube placement compared with radiologic or surgical gastrostomy: nationwide inpatient assessment
  Divyanshoo R. Kohli, Kevin F. Kennedy, Madhav Desai, Prateek Sharma
  Gastrointestinal Endoscopy.2021; 93(5): 1077.     CrossRef
• Laparoscopic vs open insertion of feeding gastrostomy tube in adults with head and neck cancers: A case‐matched comparative study
  Balqees Omari, Huthaifa Asmer, Hani Al‐Najjar, Issa Mohamad, Omar Al‐Saraireh, Basil J. Ammori
  International Journal of Clinical Practice.2021;[Epub]     CrossRef
• Percutaneous endoscopic gastrostomy
  Xudong Liu, Zhengqiang Yang, Shun He, Guiqi Wang
  International Journal of Gastrointestinal Intervention.2021; 10(2): 42.     CrossRef
• Scheduled percutaneous endoscopic gastrostomy tube replacement did not reduce PEG-related complications
  Wisam Sbeit, Anas Kadah, Amir Shahin, Samer Shbat, Moeen Sbeit, Tawfik Khoury
  Scandinavian Journal of Gastroenterology.2021; 56(11): 1386.     CrossRef
• Comparative Safety of Endoscopic vs Radiological Gastrostomy Tube Placement: Outcomes From a Large, Nationwide Veterans Affairs Database
  Divyanshoo R. Kohli, Kevin F. Kennedy, Madhav Desai, Prateek Sharma
  American Journal of Gastroenterology.2021; 116(12): 2367.     CrossRef
• ESPEN guideline on home enteral nutrition
  Stephan C. Bischoff, Peter Austin, Kurt Boeykens, Michael Chourdakis, Cristina Cuerda, Cora Jonkers-Schuitema, Marek Lichota, Ibolya Nyulasi, Stéphane M. Schneider, Zeno Stanga, Loris Pironi
  Clinical Nutrition.2020; 39(1): 5.     CrossRef
• Technical success rate and safety of radiologically inserted gastrostomy versus percutaneous endoscopic gastrostomy in motor neuron disease patients undergoing: A systematic review and meta-analysis
  Tian-wen Yuan, Yang He, Sai-bo Wang, Peng Kong, Jun Cao
  Journal of the Neurological Sciences.2020; 410: 116622.     CrossRef
• Predictors for 30-day mortality and complications following radiologically inserted gastrostomies: a single centre, large cohort review
  J. Delf, S. Jepson, S. Ramachandran, M. Elabassy, B. Morgan, R. Kenningham, J.H. Mullineux, J.A. Stephenson
  Clinical Radiology.2020; 75(5): 375.     CrossRef
• Gastropexy can be as safe as conventional percutaneous endoscopic gastrostomy (PEG), and biomarkers do not predict short-term or long-term outcomes: a 7-year follow-up audit
  Ross J Porter, Alastair W McKinlay, Emma L Metcalfe
  Frontline Gastroenterology.2020; 11(5): 364.     CrossRef
• Early versus Delayed Feeding after Percutaneous Endoscopic Gastrostomy Placement in Children: A Meta-Analysis
  Jun Watanabe, Kazuhiko Kotani
  Children.2020; 7(9): 124.     CrossRef
• Reducing 30-day post gastrostomy insertion mortality with a feeding issues multidisciplinary team meeting
  A. Bond, T. Conley, J. Fiske, V. Raymond, A. Young, P. Collins, M. Dibb, P.J. Smith
  Clinical Nutrition ESPEN.2020; 40: 282.     CrossRef
• Nutritional Support of Cancer Patients without Oral Feeding: How to Select the Most Effective Technique?
  Gonçalo Nunes, Jorge Fonseca, Ana Teresa Barata, Mário Dinis-Ribeiro, Pedro Pimentel-Nunes
  GE - Portuguese Journal of Gastroenterology.2020; 27(3): 172.     CrossRef
• Retrospective comparison of outcomes and associated complications between large bore radiologically inserted gastrostomy tube types
  David J. Tischfield, Gregory J. Nadolski, Stephen J. Hunt, Maxim Itkin, Richard D. Shlansky-Goldberg, Terence P. Gade
  Abdominal Radiology.2019; 44(1): 318.     CrossRef
• Percutaneous endoscopic gastrostomy for enteral nutrition: a 5-year clinical experience with 324 patients
  Ezekiel W. Toh Yoon, Kaori Yoneda, Kazuki Nishihara
  Minerva Gastroenterologica e Dietologica.2019;[Epub]     CrossRef
• Simple Bedside Predictors of Survival after Percutaneous Gastrostomy Tube Insertion
  Wisam Sbeit, Anas Kadah, Amir Mari, Mahmud Mahamid, Tawfik Khoury
  Canadian Journal of Gastroenterology and Hepatology.2019; 2019: 1.     CrossRef
• Risk factors for complications and mortality of percutaneous endoscopic gastrostomy insertion
  Gyu Young Pih, Hee Kyong Na, Ji Yong Ahn, Kee Wook Jung, Do Hoon Kim, Jeong Hoon Lee, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung
  BMC Gastroenterology.2018;[Epub]     CrossRef
• A Systematic Review and Meta-Analysis on Outcomes and Complications of Percutaneous Endoscopic Versus Radiologic Gastrostomy for Enteral Feeding
  Denise Strijbos, Daniel Keszthelyi, Roel M.M. Bogie, Lennard P.L. Gilissen, Martin Lacko, Janneke G.J. Hoeijmakers, Christiaan van der Leij, Rogier de Ridder, Michiel W. de Haan, Ad A.M. Masclee
  Journal of Clinical Gastroenterology.2018; 52(9): 753.     CrossRef
• Percutaneous Endoscopic Transgastric Jejunostomy (PEG‐J) Tube Placement for Levodopa‐Carbidopa Intrajejunal Gel Therapy in the Interventional Radiology Suite: A Long‐term Follow‐up
  Maria Valeria Saddi, Marianna Sarchioto, Giulia Serra, Daniela Murgia, Valeria Ricchi, Marta Melis, Roberta Arca, Pierpaolo Carreras, Loredana Sitzia, Sandro Zedda, Giovanni Dui, Rosario Rossi, Anna Ticca, Maurizio Melis, Giovanni Cossu
  Movement Disorders Clinical Practice.2018; 5(2): 191.     CrossRef
• Percutaneous Radiologically-Guided Gastrostomy (PRG): Safety, Efficacy and Trends in a Single Institution
  Gerard ZX Low, Chow Wei Too, Yen Yeong Poh, Richard HG Lo, Bien Soo Tan, Apoorva Gogna, Farah Gillan Irani, Kiang Hiong Tay
  Annals of the Academy of Medicine, Singapore.2018; 47(11): 494.     CrossRef

Citations

Citations to this article as recorded by  

• Indian consensus statements on irritable bowel syndrome in adults: A guideline by the Indian Neurogastroenterology and Motility Association and jointly supported by the Indian Society of Gastroenterology
  Uday C. Ghoshal, Sanjeev Sachdeva, Nitesh Pratap, Arun Karyampudi, Uzma Mustafa, Philip Abraham, Chetan B. Bhatt, Karmabir Chakravartty, Sujit Chaudhuri, Omesh Goyal, Govind K. Makharia, Manas Kumar Panigrahi, Prasanta Kumar Parida, Sudhanshu Patwari, Raj
  Indian Journal of Gastroenterology.2023; 42(2): 249.     CrossRef
• Current evidence for dietary therapies in irritable bowel syndrome
  Anupam Rej, Hugo A. Penny
  Current Opinion in Gastroenterology.2023; 39(3): 219.     CrossRef
• The Role of Gluten in Gastrointestinal Disorders: A Review
  Sabrina Cenni, Veronica Sesenna, Giulia Boiardi, Marianna Casertano, Giuseppina Russo, Alfonso Reginelli, Susanna Esposito, Caterina Strisciuglio
  Nutrients.2023; 15(7): 1615.     CrossRef
• Gluten restriction in irritable bowel syndrome, yes or no?: a GRADE-assessed systematic review and meta-analysis
  Erfan Arabpour, Dorsa Alijanzadeh, Amir Sadeghi, Sina Khoshdel, Azita Hekmatdoost, Hamed Kord-Varkaneh, Mohammad Abdehagh
  Frontiers in Nutrition.2023;[Epub]     CrossRef
• Boosting biomedical document classification through the use of domain entity recognizers and semantic ontologies for document representation: The case of gluten bibliome
  Martín Pérez-Pérez, Tânia Ferreira, Anália Lourenço, Gilberto Igrejas, Florentino Fdez-Riverola
  Neurocomputing.2022; 484: 223.     CrossRef
• Management of bloating
  Jordi Serra
  Neurogastroenterology & Motility.2022;[Epub]     CrossRef
• Evidence-Based and Emerging Diet Recommendations for Small Bowel Disorders
  Anupam Rej, Michael D. E. Potter, Nicholas J. Talley, Ayesha Shah, Gerald Holtmann, David Surendran Sanders
  American Journal of Gastroenterology.2022; 117(6): 958.     CrossRef
• Gluten-free grains: Importance, processing and its effect on quality of gluten-free products
  Samandeep Kaur, Kshitiz Kumar, Lochan Singh, Vijay Singh Sharanagat, Prabhat K. Nema, Vijendra Mishra, Bharat Bhushan
  Critical Reviews in Food Science and Nutrition.2022; : 1.     CrossRef
• Diet and irritable bowel syndrome: an update from a UK consensus meeting
  A. Rej, A. Avery, I. Aziz, C. J. Black, R. K. Bowyer, R. L. Buckle, L. Seamark, C. C. Shaw, J. Thompson, N. Trott, M. Williams, D. S. Sanders
  BMC Medicine.2022;[Epub]     CrossRef
• Belgian consensus on irritable bowel syndrome
  S Kindt, H Louis, H De Schepper, J Arts, P Caenepeel, D De Looze, A Gerkens, T Holvoet, P Latour, T Mahler, F Mokaddem, S Nullens, H Piessevaux, P Poortmans, G Rasschaert, M Surmont, H Vafa, K Van Malderen, T Vanuytsel, F Wuestenberghs, J Tack
  Acta Gastro Enterologica Belgica.2022; 85(2): 360.     CrossRef
• A food pyramid, based on a review of the emerging literature, for subjects with inflammatory bowel disease
  Mariangela Rondanelli, Silvia Lamburghini, Milena A. Faliva, Gabriella Peroni, Antonella Riva, Pietro Allegrini, Daniele Spadaccini, Clara Gasparri, Giancarlo Iannello, Vittoria Infantino, Tariq A. Alalwan, Simone Perna, Alessandra Miccono
  Endocrinología, Diabetes y Nutrición.2021; 68(1): 17.     CrossRef
• Non-responsive celiac disease may coincide with additional food intolerance/malabsorption, including histamine intolerance
  Wolfgang J. Schnedl, Harald Mangge, Michael Schenk, Dietmar Enko
  Medical Hypotheses.2021; 146: 110404.     CrossRef
• Non-celiac wheat sensitivity: rationality and irrationality of a gluten-free diet in individuals affected with non-celiac disease: a review
  Consolato Sergi, Vincenzo Villanacci, Antonio Carroccio
  BMC Gastroenterology.2021;[Epub]     CrossRef
• Personalizing Dietary Therapies For Irritable Bowel Syndrome: What Is Gluten’s Role?
  Anupam Rej, Imran Aziz, David S. Sanders
  Clinical Gastroenterology and Hepatology.2021; 19(11): 2270.     CrossRef
• A food pyramid, based on a review of the emerging literature, for subjects with inflammatory bowel disease
  Mariangela Rondanelli, Silvia Lamburghini, Milena A. Faliva, Gabriella Peroni, Antonella Riva, Pietro Allegrini, Daniele Spadaccini, Clara Gasparri, Giancarlo Iannello, Vittoria Infantino, Tariq A. Alalwan, Simone Perna, Alessandra Miccono
  Endocrinología, Diabetes y Nutrición (English ed.).2021; 68(1): 17.     CrossRef
• Histamine Intolerance Originates in the Gut
  Wolfgang J. Schnedl, Dietmar Enko
  Nutrients.2021; 13(4): 1262.     CrossRef
• Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms
  Annamaria Altomare, Claudia Di Rosa, Elena Imperia, Sara Emerenziani, Michele Cicala, Michele Pier Luca Guarino
  Nutrients.2021; 13(5): 1506.     CrossRef
• Adherence to treatment of patients with irritable bowel syndrome: state of the issue
  S.A. Sukhanova, A.Yu. Timakova, M.A. Livzan, M.M. Fedorin, Yu.P. Skirdenko, O.V. Gaus, K.A. Andreev, A.V. Gorbenko, M.I. Plinder
  Profilakticheskaya meditsina.2021; 24(8): 101.     CrossRef
• Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastr
  P. Layer, V. Andresen, H. Allescher, S. C. Bischoff, M. Claßen, S. Elsenbruch, M. Freitag, T. Frieling, M. Gebhard, M. Goebel-Stengel, W. Häuser, G. Holtmann, J. Keller, M. E. Kreis, W. Kruis, J. Langhorst, P. Lynen Jansen, A. Madisch, H. Mönnikes, S. Mül
  Zeitschrift für Gastroenterologie.2021; 59(12): 1323.     CrossRef
• Nutrition in Patients with Lactose Malabsorption, Celiac Disease, and Related Disorders
  Michele J. Alkalay
  Nutrients.2021; 14(1): 2.     CrossRef
• Letter: the gluten‐free diet as a bottom‐up approach for irritable bowel syndrome
  Anupam Rej, Rachel Louise Buckle, Christian Charles Shaw, Nick Trott, Imran Aziz, David Surendran Sanders
  Alimentary Pharmacology & Therapeutics.2020; 51(1): 184.     CrossRef
• Irritable Bowel Syndrome and Gluten-Related Disorders
  Paolo Usai-Satta, Gabrio Bassotti, Massimo Bellini, Francesco Oppia, Mariantonia Lai, Francesco Cabras
  Nutrients.2020; 12(4): 1117.     CrossRef
• Ernährungsmedizinische Aspekte beim Reizdarmsyndrom – ein Update
  Larissa Hetterich, Andreas Stengel
  Aktuelle Ernährungsmedizin.2020; 45(04): 276.     CrossRef
• The Two Faces of Wheat
  Herbert Wieser, Peter Koehler, Katharina A. Scherf
  Frontiers in Nutrition.2020;[Epub]     CrossRef
• Low Fermentable Oligo- Di- and Mono-Saccharides and Polyols (FODMAPs) or Gluten Free Diet: What Is Best for Irritable Bowel Syndrome?
  Massimo Bellini, Sara Tonarelli, Maria Gloria Mumolo, Francesco Bronzini, Andrea Pancetti, Lorenzo Bertani, Francesco Costa, Angelo Ricchiuti, Nicola de Bortoli, Santino Marchi, Alessandra Rossi
  Nutrients.2020; 12(11): 3368.     CrossRef
• Breaking bread!
  Anupam Rej, Imran Aziz, David Surendran Sanders
  Proceedings of the Nutrition Society.2019; 78(1): 118.     CrossRef
• Efficacy of the gluten free diet in the management of functional gastrointestinal disorders: a systematic review on behalf of the Italian Society of Paediatrics
  Elena Scarpato, Renata Auricchio, Francesca Penagini, Angelo Campanozzi, Gian Vincenzo Zuccotti, Riccardo Troncone
  Italian Journal of Pediatrics.2019;[Epub]     CrossRef
• The overlap of irritable bowel syndrome and noncoeliac gluten sensitivity
  Anupam Rej, David S. Sanders
  Current Opinion in Gastroenterology.2019; 35(3): 199.     CrossRef
• Gluten Vehicle and Placebo for Non-Celiac Gluten Sensitivity Assessment
  Oscar Gerardo Figueroa-Salcido, Noé Ontiveros, Francisco Cabrera-Chavez
  Medicina.2019; 55(5): 117.     CrossRef
• The role of diet in irritable bowel syndrome: implications for dietary advice
  A. Rej, I. Aziz, H. Tornblom, D. S. Sanders, M. Simrén
  Journal of Internal Medicine.2019; 286(5): 490.     CrossRef
• Does Irritable Bowel Syndrome Exist? Identifiable and Treatable Causes of Associated Symptoms Suggest It May Not
  Benjamin I. Brown
  Gastrointestinal Disorders.2019; 1(3): 314.     CrossRef
• Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm
  Giuseppe Losurdo, Mariabeatrice Principi, Andrea Iannone, Annacinzia Amoruso, Enzo Ierardi, Alfredo Di Leo, Michele Barone
  World Journal of Gastroenterology.2018; 24(14): 1521.     CrossRef
• Is an enzyme supplement for celiac disease finally on the cards?
  Julia König, Robert J. Brummer
  Expert Review of Gastroenterology & Hepatology.2018; 12(6): 531.     CrossRef
• Non-celiac gluten sensitivity: people without celiac disease avoiding gluten—is it due to histamine intolerance?
  Wolfgang J. Schnedl, Sonja Lackner, Dietmar Enko, Michael Schenk, Harald Mangge, Sandra J. Holasek
  Inflammation Research.2018; 67(4): 279.     CrossRef
• Gluten sensitivities and the allergist: Threshing the grain from the husks
  J. G. Burkhardt, A. Chapa‐Rodriguez, S. L. Bahna
  Allergy.2018; 73(7): 1359.     CrossRef
• Prevalence and factors associated with gluten sensitivity in inflammatory bowel disease
  Berkeley N. Limketkai, Rachel Sepulveda, Tressia Hing, Neha D. Shah, Monica Choe, David Limsui, Shamita Shah
  Scandinavian Journal of Gastroenterology.2018; 53(2): 147.     CrossRef
• Non‐celiac gluten or wheat sensitivity: It's complicated!
  Maria I. Pinto‐Sanchez, Elena F. Verdu
  Neurogastroenterology & Motility.2018;[Epub]     CrossRef
• Canadian packaged gluten-free foods are less nutritious than their regular gluten-containing counterparts
  Jennifer A. Jamieson, Mary Weir, Laura Gougeon
  PeerJ.2018; 6: e5875.     CrossRef
• Consensus document on exclusion diets in irritable bowel syndrome (IBS)
  Francesc Casellas, Rosa Burgos, Ascensión Marcos, Javier Santos, Constanza Ciriza de los Ríos, Álvaro García Manzanares, Isabel Polanco, María Puy Portillo, Antonio Villarino, Beatriz Lema Marqués, María del Carmen Vázquez Alférez
  Revista Española de Enfermedades Digestivas.2018;[Epub]     CrossRef
• Gluten-Free Diet and Its ‘Cousins’ in Irritable Bowel Syndrome
  Anupam Rej, David Surendran Sanders
  Nutrients.2018; 10(11): 1727.     CrossRef
• IRRITABLE BOWEL SYNDROME, FOOD INTOLERANCE AND NON- CELIAC GLUTEN SENSITIVITY. A NEW CLINICAL CHALLENGE
  Rosa Leonôra Salerno SOARES
  Arquivos de Gastroenterologia.2018; 55(4): 417.     CrossRef
• Randomized clinical trial: Effective gluten degradation by Aspergillus niger-derived enzyme in a complex meal setting
  Julia König, Savanne Holster, Maaike J. Bruins, Robert J. Brummer
  Scientific Reports.2017;[Epub]     CrossRef
• The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An Update
  Carlo Catassi, Armin Alaedini, Christian Bojarski, Bruno Bonaz, Gerd Bouma, Antonio Carroccio, Gemma Castillejo, Laura De Magistris, Walburga Dieterich, Diana Di Liberto, Luca Elli, Alessio Fasano, Marios Hadjivassiliou, Matthew Kurien, Elena Lionetti, Ch
  Nutrients.2017; 9(11): 1268.     CrossRef
• Irritable bowel syndrome and diet
  Eirini Dimidi, Megan Rossi, Kevin Whelan
  Current Opinion in Clinical Nutrition & Metabolic Care.2017; 20(6): 456.     CrossRef
• Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients!
  Anamaria Cozma-Petruţ, Felicia Loghin, Doina Miere, Dan Lucian Dumitraşcu
  World Journal of Gastroenterology.2017; 23(21): 3771.     CrossRef

Citations

Citations to this article as recorded by  

• Association of Poor Differentiation or Positive Vertical Margin with Residual Disease in Patients with Subsequent Colectomy after Complete Macroscopic Endoscopic Resection of Early Colorectal Cancer
  Ki Ju Kim, Hyun Seok Lee, Seong Woo Jeon, Sun Jin, Sang Won Lee
  Gastroenterology Research and Practice.2017; 2017: 1.     CrossRef
• Derivation and validation of a risk scoring model to predict advanced colorectal neoplasm in adults of all ages
  Hyo‐Joon Yang, Sungkyoung Choi, Soo‐Kyung Park, Yoon Suk Jung, Kyu Yong Choi, Taesung Park, Ji Yeon Kim, Dong Il Park
  Journal of Gastroenterology and Hepatology.2017; 32(7): 1328.     CrossRef
• Screening strategy for colorectal cancer according to risk
  Dong Soo Han
  Journal of the Korean Medical Association.2017; 60(11): 893.     CrossRef

Citations

Citations to this article as recorded by  

• Delays in definitive endoscopic resection of previously manipulated colorectal polyps as a risk factor for inferior resection outcomes
  Fares Ayoub, Grace E. Kim, Wenfei Wang, Dennis Chen, Uzma D. Siddiqui
  Gastrointestinal Endoscopy.2024; 100(1): 109.     CrossRef
• Is there a best choice of equipment for colorectal endoscopic submucosal dissection?
  Francesco Cocomazzi, Sonia Carparelli, Nunzia Labarile, Antonio Capogreco, Marco Gentile, Roberta Maselli, Jahnvi Dhar, Jayanta Samanta, Alessandro Repici, Cesare Hassan, Francesco Perri, Antonio Facciorusso
  Expert Review of Medical Devices.2024; : 1.     CrossRef
• Risk Factors for Post-Endoscopic Submucosal Dissection Electrocoagulation Syndrome in Patients with Colorectal Neoplasms: A Multicenter, Large-Scale, Retrospective Cohort Study by the Honam Association for the Study of Intestinal Disease (HASID)
  Hyo-Yeop Song, Seong-Jung Kim, Jun Lee, Byung Chul Jin, Dong Hyun Kim, Hyun-Soo Kim, Hyung-Hoon Oh, Young-Eun Joo, Dae-Seong Myung, Sang-Wook Kim, Geom-Seog Seo
  Journal of Clinical Medicine.2024; 13(13): 3932.     CrossRef
• Hybrid Versus Conventional Colorectal Endoscopic Submucosal Dissection: A Multicenter Randomized Controlled Trial (Short-Endoscopic Submucosal Dissection)
  Dennis Yang, Muhammad K. Hasan, Salmaan Jawaid, Gurdeep Singh, Yasi Xiao, Mai Khalaf, Yutaka Tomizawa, Neil S. Sharma, Peter V. Draganov, Mohamed O. Othman
  American Journal of Gastroenterology.2024;[Epub]     CrossRef
• The Derivation and External Validation of a Fibrosis Risk Model for Colorectal Tumours Undergoing Endoscopic Submucosal Dissection
  Sandro Sferrazza, Marcello Maida, Giulio Calabrese, Antonio Facciorusso, Lorenzo Fuccio, Leonardo Frazzoni, Roberta Maselli, Alessandro Repici, Roberto Di Mitri, João Santos-Antunes
  Journal of Clinical Medicine.2024; 13(15): 4517.     CrossRef
• Outcomes and Learning Curve in Endoscopic Submucosal Dissection of Rectal Neoplasms with Severe Fibrosis: Experience of a Western Center
  Catarina Félix, Pedro Barreiro, Rui Mendo, André Mascarenhas, Cristina Chagas
  GE - Portuguese Journal of Gastroenterology.2023; 30(3): 221.     CrossRef
• Endoscopic submucosal dissection for colorectal polyps: outcome determining factors
  Chi Woo Samuel Chow, Tak Lit Derek Fung, Pak Tat Chan, Kam Hung Kwok
  Surgical Endoscopy.2023; 37(2): 1293.     CrossRef
• Safety and feasibility of same-day discharge after endoscopic submucosal dissection: a Western multicenter prospective cohort study
  William King, Peter Draganov, V.Subhash Gorrepati, Maham Hayat, Hiroyuki Aihara, Michael Karasik, Saowanee Ngamruengphong, Abdul Aziz Aadam, Mohamed O. Othman, Neil Sharma, Ian S. Grimm, Alaa Rostom, B. Joseph Elmunzer, Dennis Yang
  Gastrointestinal Endoscopy.2023; 97(6): 1045.     CrossRef
• Is colorectal endoscopic submucosal dissection safe and effective for 15–19-mm tumors?
  Yunho Jung, Young Hwangbo, Young Sin Cho, Seong Woo Choi, Seong Ran Jeon, Hyun Gun Kim, Bong Min Ko, Jin-O Kim
  International Journal of Colorectal Disease.2023;[Epub]     CrossRef
• Initial multicenter experience using a novel articulating through-the-scope traction device for endoscopic submucosal dissection
  Maham Hayat, Alexander Schlachterman, Grace Schiavone, Meir Mizrahi, Jong Kyu Park, Vivek Kumbhari, Antonio Cheesman, Peter V Draganov, Muhammad Khalid Hasan, Dennis Yang
  Endoscopy International Open.2023; 11(08): E778.     CrossRef
• Novel beagle model of gastric local fibrotic target lesions for the evaluation and training of endoscopic techniques
  Xiao-Jian He, Xiao-Ling Wang, Chuan-Shen Jiang, Dong-Gui Hong, Hai-Lan Lin, Yun-Ping Zheng, Han Li, Xin-Jiang Chen, Jian-Xiao Huang, Ling-Shuang Dai, Mei-Yan Liu, Bao-Xiang Luo, Dong-Liang Li, Da-Zhou Li, Wen Wang
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Comparison of precutting endoscopic mucosal resection and endoscopic submucosal dissection for large (20–30 mm) flat colorectal lesions
  Chang Kyo Oh, Young Wook Cho, In Hyoung Choi, Han Hee Lee, Chul‐Hyun Lim, Jin Su Kim, Bo‐In Lee, Young‐Seok Cho
  Journal of Gastroenterology and Hepatology.2022; 37(3): 568.     CrossRef
• Endoscopic Submucosal Dissection in North America: A Large Prospective Multicenter Study
  Peter V. Draganov, Hiroyuki Aihara, Michael S. Karasik, Saowanee Ngamruengphong, Abdul Aziz Aadam, Mohamed O. Othman, Neil Sharma, Ian S. Grimm, Alaa Rostom, B. Joseph Elmunzer, Salmaan A. Jawaid, Donevan Westerveld, Yaseen B. Perbtani, Brenda J. Hoffman,
  Gastroenterology.2021; 160(7): 2317.     CrossRef
• Pocket-creation method improves efficacy of colorectal endoscopic submucosal dissection: a system review and meta-analysis
  Jian Gong, Tong Chen, Yuyong Tan, Deliang Liu
  European Journal of Gastroenterology & Hepatology.2021; 33(10): 1241.     CrossRef
• Impact of Procedure Time of Preceding Endoscopic Submucosal Dissection on the Difficulty of Laparoscopic Rectal Surgery
  Hiroaki Nozawa, Kazushige Kawai, Kazuhito Sasaki, Shigenobu Emoto, Koji Murono, Hirofumi Sonoda, Hiroaki Ishii, Soichiro Ishihara
  International Surgery.2021; 105(1-3): 528.     CrossRef
• Factors Associated with Fibrosis during Colorectal Endoscopic Submucosal Dissection: Does Pretreatment Biopsy Potentially Elicit Submucosal Fibrosis and Affect Endoscopic Submucosal Dissection Outcomes?
  Masatake Kuroha, Hisashi Shiga, Yoshitake Kanazawa, Hiroshi Nagai, Tomoyuki Handa, Ryo Ichikawa, Motoyuki Onodera, Takeo Naito, Rintaro Moroi, Tomoya Kimura, Katsuya Endo, Yoichi Kakuta, Yoshitaka Kinouchi, Tooru Shimosegawa, Atsushi Masamune
  Digestion.2021; 102(4): 590.     CrossRef
• Endoscopic submucosal dissection in rectal tumors extending or not to the dentate line: A comparative analysis
  Déborah Roland, Gabriel Rahmi, Enrique Pérez-Cuadrado-Robles, Guillaume Perrod, Jérémie Jacques, Maximilien Barret, Sarah Leblanc, Arthur Berger, Jérémie Albouys, Stanislas Chaussade, Christophe Cellier
  Digestive and Liver Disease.2020; 52(3): 296.     CrossRef
• Novel approach to endoscopic submucosal dissection of a cecal lesion with nonlifting sign by submucosal fatty tissue with use of selective-regulation high-pressure water-jet method and immersion in saline solution
  Felipe Ramos-Zabala, Sabina Beg, Marian García-Mayor, Adolfo Parra-Blanco, Luis Moreno-Almazán
  VideoGIE.2020; 5(3): 116.     CrossRef
• Review on colorectal endoscopic submucosal dissection focusing on the technical aspect
  Tak Lit Derek Fung, Chi Woo Samuel Chow, Pak Tat Chan, Kam Hung Kwok
  Surgical Endoscopy.2020; 34(9): 3766.     CrossRef
• Endoscopic Biopsy in Differential Diagnosis of Colorectal Serrated Lesions
  K. D. Khalin, M. Yu. Agapov, L. V. Zvereva, K. V. Stegniy
  Russian Journal of Gastroenterology, Hepatology, Coloproctology.2020; 30(3): 42.     CrossRef
• Predictors for Submucosal Fibrosis in Patients With Superficial Squamous Esophageal Neoplasia Undergoing Endoscopic Submucosal Dissection
  Xiaoduan Zhuang, Ming Xu, Zhenyu Chen, Jianqi Wang, Kai Qian, Shihao Wang, Guoming Deng, Yang Bai
  Clinical and Translational Gastroenterology.2020; 11(8): e00188.     CrossRef
• Hybrid resection with ESD and FTRD: Could this be a rescue treatment in the presence of severe submucosal fibrosis?
  Gianluca Andrisani, Francesco Maria Di Matteo
  Digestive and Liver Disease.2019; 51(4): 607.     CrossRef
• Factors Predictive of Complete Excision of Large Colorectal Neoplasia Using Hybrid Endoscopic Submucosal Dissection: A KASID Multicenter Study
  Yunho Jung, Jong Wook Kim, Jeong-Sik Byeon, Hoon Sup Koo, Sun-Jin Boo, Jun Lee, Young Hwangbo, Yoon Mi Jeen, Hyun Gun Kim
  Digestive Diseases and Sciences.2018; 63(10): 2773.     CrossRef
• Perforation and Postoperative Bleeding Associated with Endoscopic Submucosal Dissection in Colorectal Tumors: An Analysis of 398 Lesions Treated in Saga, Japan
  Koji Yamamoto, Ryo Shimoda, Shinichi Ogata, Megumi Hara, Yoichiro Ito, Naoyuki Tominaga, Atsushi Nakayama, Yasuhisa Sakata, Nanae Tsuruoka, Ryuichi Iwakiri, Kazuma Fujimoto
  Internal Medicine.2018; 57(15): 2115.     CrossRef
• The efficacy of the pocket-creation method for cases with severe fibrosis in colorectal endoscopic submucosal dissection
  Naohisa Yoshida, Yuji Naito, Ritsu Yasuda, Takaaki Murakami, Ryohei Hirose, Kiyoshi Ogiso, Yutaka Inada, Hideyuki Konishi, Rafiz Abdul Rani, Mitsuo Kishimoto, Eiichi Konishi, Masayoshi Nakanishi, Yoshito Itoh
  Endoscopy International Open.2018; 06(08): E975.     CrossRef
• Local recurrence and subsequent endoscopic treatment after endoscopic piecemeal mucosal resection with or without precutting in the colorectum
  Myeongsook Seo, Eun Mi Song, Gwang Un Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Seung-Jae Myung, Suk-Kyun Yang, Jeong-Sik Byeon
  Intestinal Research.2017; 15(4): 502.     CrossRef

Pyoderma gangrenosum (PG) is an uncommon extra-intestinal manifestation of inflammatory bowel disease (IBD). Despite limited published literature, biologics have caused a paradigm shift in the management of this difficult-to-treat skin condition. The clinical data and outcomes of three patients with active ulcerative colitis and concurrent PG treated with biologics (infliximab two and adalimumab one) are reviewed in this report. Biologics were added because of the sub-optimal response of the colonic symptoms and skin lesions to parenteral hydrocortisone therapy. All three patients showed a dramatic response to the addition of the biologics. In view of the rapid healing of the skin lesions, superior response rate, and the additional benefit of improvement in the underlying colonic disease following treatment, anti-tumor necrosis factor blockers should be considered as a first line therapy in the management of PG with underlying IBD.

Citations

Citations to this article as recorded by  

• Multiple extraintestinal manifestations in a patient with acute severe ulcerative colitis: a case report
  Eun Young Park, Dong Hoon Baek, Seung Min Hong, Geun Am Song
  Kosin Medical Journal.2022; 37(4): 361.     CrossRef
• Effective use of switching biologics for ulcerative colitis complicated with pyoderma gangrenosum and primary sclerosing cholangitis
  Kenta Iwahashi, Yuichiro Kuroki, Yuichi Takano, Masatsugu Nagahama
  BMJ Case Reports.2021; 14(5): e241744.     CrossRef
• Treatment of Pyoderma Gangrenosum in Pediatric Inflammatory Bowel Disease
  Katherine Vaidy, Rebecca Winderman, Simon S. Rabinowitz, Steven M. Schwarz
  JPGN Reports.2020; 1(2): e008.     CrossRef
• Idiopathic pyoderma gangrenosum or a systemic disease predictor?
  Todor Yordanov, Jenya Dimitrova, Ivanka Temelkova, Tsveta Kalinova, Neli Koleva, Sonya Marina
  Scripta Scientifica Medica.2020; 52(3): 27.     CrossRef
• Biologic and small-molecule medications in the management of pyoderma gangrenosum
  Fatima McKenzie, Devin Cash, Angela Gupta, Laurel W. Cummings, Alex G. Ortega-Loayza
  Journal of Dermatological Treatment.2019; 30(3): 264.     CrossRef
• Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi‐systematic review
  Hakim Ben Abdallah, Karsten Fogh, Rikke Bech
  International Wound Journal.2019; 16(2): 511.     CrossRef
• Pyoderma gangrenosum successfully treated with golimumab: Case report and review of the literature
  Federico Diotallevi, Anna Campanati, Giulia Radi, Valerio Brisigotti, Elisa Molinelli, Donatella Brancorsini, Annamaria Offidani
  Dermatologic Therapy.2019; : e12928.     CrossRef
• A Case of Pyoderma Gangrenosum Misdiagnosed as Necrotizing Infection: A Potential Diagnostic Catastrophe
  Medina G. Saffie, Anjali Shroff
  Case Reports in Infectious Diseases.2018; 2018: 1.     CrossRef
• Hyperbaric oxygen therapy for pyoderma gangrenosum associated with ulcerative colitis
  Hyun Il Seo, Hyun-Ju Lee, Koon Hee Han
  Intestinal Research.2018; 16(1): 155.     CrossRef
• A RARE CASE OF CROHN DISEASE COMPLICATED WITH STEROID MONOTHERAPY-RELATED RETROPHARYNGEAL ABSCESS AND INITIALLY MISINTERPRETED PYODERMA GANGRENOSUM DEVELOPMENT
  Michael Doulberis, Jörg Dähn, Jannis Kountouras, Volker Maier, Arthur Helbling, Patrick Dubach
  Gastroenterology Nursing.2018; 41(4): 347.     CrossRef
• Successful treatment with tacrolimus of refractory pyoderma gangrenosum with pouchitis after restorative proctocolectomy for ulcerative colitis
  Miwa Satake, Hirotake Sakuraba, Hiroto Hiraga, Natsumi Tarakita, Yui Akemoto, Shinji Ota, Keisuke Hasui, Daisuke Nishiya, Shiro Hayamizu, Hidezumi Kikuchi, Manabu Sawaya, Daisuke Chinda, Tatsuya Mikami, Tadashi Shimoyama, Shinsaku Fukuda
  Immunological Medicine.2018; 41(3): 142.     CrossRef

A 57-year-old man with chronic kidney disease and a history of using numerous herbal medications visited Inje University Ilsan Paik Hospital for abdominal pain and vomiting. An abdominal radiograph showed diffuse small bowel distension containing multiple air-fluid levels and extensive calcifications along the colon. Computed tomography showed colon wall thickening with diffuse calcification along the colonic mesenteric vein and colonic wall. Colonoscopy, performed without bowel preparation, showed bluish edematous mucosa from the transverse to the distal sigmoid colon, with multiple scar changes. At the mid transverse colon, a stricture was noted and the scope could not pass through. A biopsy of the stricture site revealed nonspecific changes. The patient was diagnosed with phlebosclerotic colitis. After the colonoscopy, the obstructive ileus spontaneously resolved, and the patient was discharged without an operation. Currently, after 2 months of follow-up, the patient has remained asymptomatic. Herein, we report the rare case of an obstructive ileus caused by phlebosclerotic colitis with a colon stricture.

Citations

Citations to this article as recorded by  

• Phlebosclerotic colitis with long-term herbal medicine use
  Nguyen Dinh Minh, Nguyen Duy Hung, Pham Thu Huyen, Nguyen Thanh Van Anh, Nguyen Sy Lanh, Pham Quynh Anh, Nguyen Minh Duc
  Radiology Case Reports.2022; 17(5): 1696.     CrossRef
• Adverse Events Associated with Ethical Kampo Formulations: Analysis of the Domestic Adverse-Event Data Reports of the Ministry of Health, Labor, and Welfare in Japan
  Yutaka Shimada, Makoto Fujimoto, Tatsuya Nogami, Hidetoshi Watari
  Evidence-Based Complementary and Alternative Medicine.2019; 2019: 1.     CrossRef
• Phlebosclerotic colitis
  Wenguo Chen, Huatuo Zhu, Hongtan Chen, Guodong Shan, Guoqiang Xu, Lihua Chen, Fei Dong
  Medicine.2018; 97(43): e12824.     CrossRef
• Exclusive Phlebosclerosis of Submucosal Veins Leading to Ischemic Necrosis and Perforation of the Large Bowel: First European Case
  Sebastian Klein, Denise Buchner, De-hua Chang, Reinhard Büttner, Uta Drebber, Jochen W.U. Fries
  Case Reports in Gastroenterology.2018; 12(1): 137.     CrossRef

Sclerosing encapsulating peritonitis (SEP) is a rare cause of bowel obstruction that is characterized by the encasement of the small bowel by a thick, whitish, and fibrous membrane. The pathophysiology of SEP is poorly understood and preoperative diagnosis is difficult. Previous reports suggest that SEP may be linked to the chronic use of β-adrenergic blockers. A 46-year-old man with liver cirrhosis and end-stage renal disease on hemodialysis presented with recurrent abdominal pain and borborygmi. He had been taking propranolol to prevent bleeding from gastroesophageal varices for the past 15 years. Abdominal computed tomography showed ileal loops encapsulated by soft tissue with dilatation of the proximal small bowel on the right side of the abdomen. Barium follow-through showed conglomerated distal ileal loops with a cauliflower-like appearance. Explorative laparotomy revealed a thick, fibrous, whitish capsule encapsulating the ileal loops. The covering membrane was dissected and excised, resulting in an improvement in symptoms after surgery. Accordingly, a final diagnosis of SEP was made. Due to the lack of other apparent causes for SEP, we conclude that in this case, the long-term use of propranolol may be associated with the development of SEP.

Citations

Citations to this article as recorded by  

• Surgical timing for primary encapsulating peritoneal sclerosis: A case report and review of literature
  Peng Deng, Long-Xin Xiong, Ping He, Jian-Hua Hu, Qi-Xu Zou, Shi-Lian Le, Sen-Lin Wen
  World Journal of Gastrointestinal Surgery.2022; 14(4): 352.     CrossRef
• Sclerosing Encapsulating Peritonitis in a Pediatric Patient Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  Richard S. Whitlock, Tahir Malik, Valeria Smith, Priya Mahajan, Andrea Hayes-Jordan, Sanjeev A. Vasudevan
  Journal of Pediatric Hematology/Oncology.2021; 43(5): e685.     CrossRef
• Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use
  Jennifer C Asotibe, Pejman Zargar, Ikechukwu Achebe, Benjamin Mba, Vikram Kotwal
  Cureus.2020;[Epub]     CrossRef
• Peritoneal encapsulation: A puzzling encounter during open and laparoscopic surgery
  MEzzedien Rabie, Asim Elyas, Mohammad Bazeed, Mohammad Osama, HanaAhmed Alhashemy
  Saudi Surgical Journal.2019; 7(2): 75.     CrossRef
• Sclerosing encapsulating peritonitis presenting as acute-on-chronic small-bowel obstruction in a patient with history of peritoneal carcinomatosis
  Roy Hajjar, Éric Debroux, Carole Richard, Marylène Plasse, Rasmy Loungnarath
  Journal of Surgical Case Reports.2018;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Quality of Care in Inflammatory Bowel Disease: the Role of Steroid Assessment Tool (SAT) - a Review
  Loredana GORAN, Monica STATE, Ana NEGREANU, Lucian NEGREANU
  Medicina Moderna - Modern Medicine.2020; 27(3): 171.     CrossRef